12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Company News  |  Deals

Amunix, Biogen Idec deal

Amunix partnered with Biogen Idec to research and develop Factors IX, VIII and VIIa using Amunix's recombinant XTEN technology to treat...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >